Takeda Pharmaceutical (TAK) Current Taxes: 2018-2025
- Takeda Pharmaceutical's Current Taxes rose 17.99% to $875.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $875.0 million, marking a year-over-year increase of 17.99%. This contributed to the annual value of $876.4 million for FY2025, which is 15.00% up from last year.
- Takeda Pharmaceutical's Current Taxes amounted to $875.0 million in Q1 2025, which was up 17.99% from $741.6 million recorded in Q1 2024.
- Takeda Pharmaceutical's Current Taxes' 5-year high stood at $1.8 billion during Q1 2023, with a 5-year trough of $741.6 million in Q1 2024.
- Over the past 3 years, Takeda Pharmaceutical's median Current Taxes value was $875.0 million (recorded in 2025), while the average stood at $1.1 billion.
- In the last 5 years, Takeda Pharmaceutical's Current Taxes increased by 26.03% in 2022 and then plummeted by 57.78% in 2024.
- Over the past 5 years, Takeda Pharmaceutical's Current Taxes (Quarterly) stood at $1.4 billion in 2021, then grew by 26.03% to $1.7 billion in 2022, then rose by 1.61% to $1.8 billion in 2023, then plummeted by 57.78% to $741.6 million in 2024, then grew by 17.99% to $875.0 million in 2025.
- Its last three reported values are $875.0 million in Q1 2025, $741.6 million for Q1 2024, and $1.8 billion during Q1 2023.
